Professor Daniel M Altmann

Publications


Journals

  • Chu KK; Tippayawat P; Walker NJ; Harding SV; Atkins HS; Maillere B; Bancroft GJ; Lertmemongkolchai G; et alAltmann DM. (Jan 2011). CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis. Eur J Immunol. 41:107-115. DOI.
  • Chu KK; Tippayawat P; Walker NJ; Harding SV; Atkins HS; Maillere B; Bancroft GJ; Lertmemongkolchai G; et alAltmann DM. (Jan 2011). CD4(+) T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis. Eur J Immunol. 41:107-115. DOI.
  • Baillie LW; Huwar TB; Moore S; Mellado-Sanchez G; Rodriguez L; Neeson BN; Flick-Smith HC; Jenner DC; et alAtkins HS; Ingram RJ; Altmann DM; Nataro JP; Pasetti MF. (24 Sep 2010). An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor. Vaccine. 28:6740-6748. DOI.
  • Kotturi MF; Botten J; Maybeno M; Sidney J; Glenn J; Bui HH; Oseroff C; Crotty S; et alPeters B; Grey H; Altmann DM; Buchmeier MJ; Sette A. (2010). Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage. Immunome Res. 6:4. DOI.
  • Ingram RJ; Chu KK; Metan G; Maillere B; Doganay M; Ozkul Y; Dyson H; Williamson ED; et alBaillie L; Kim LU; Ascough S; Sriskandan S; Altmann DM. (May 2010). An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans. Infect Immun. 78:2353. DOI.
  • Ingram RJ; Metan G; Maillere B; Doganay M; Ozkul Y; Kim LU; Baillie L; Dyson H; et alWilliamson ED; Chu KK; Ascough S; Moore S; Huwar TB; Robinson JH; Sriskandan S; Altmann DM. (1 Apr 2010). Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes. J Immunol. 184:3814-3821. DOI.
  • Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A. (1 Sep 2009). HLA-DR Alleles in Amyloid beta-Peptide Autoimmunity: A Highly Immunogenic Role for the DRB1*1501 Allele. J IMMUNOL. 183:3522-3530. DOI.
  • Campbell JD; Buckland KF; McMillan SJ; Kearley J; Oldfield WLG; Stern LJ; Gronlund H; van Hage M; et alReynolds CJ; Boyton RJ; Cobbold SP; Kay AB; Altmann DM; Lloyd CM; Larche M. (6 Jul 2009). Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J EXP MED. 206:1535-1547. DOI.
  • Call MJ; Xing XC; Cuny GD; Seth NP; Altmann DM; Fugger L; Krogsgaard M; Stein RL; et alWucherpfennig KW. (15 May 2009). In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange. J IMMUNOL. 182:6342-6352. DOI.
  • Ingram RJ; Isaacs JD; Kaur G; Lowther DE; Reynolds CJ; Boyton RJ; Collinge J; Jackson GS; et alAltmann DM. (Jun 2009). A role of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J. 23:1672-1684. DOI.
  • Altmann DM. (Jan 2009). Review series on helminths, immune modulation and the hygiene hypothesis: Nematode coevolution with adaptive immunity, regulatory networks and the growth of inflammatory diseases. IMMUNOLOGY. 126:1-2. DOI.
  • Isaacs JD; Garden OA; Kaur G; Collinge J; Jackson GS; Altmann DM. (Nov 2008). The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells. Immunology. 125:313-319. DOI.
  • Sriskandan S; Altmann DM. (Jan 2008). The immunology of sepsis. J PATHOL. 214:211-223. DOI.
  • Boyton RJ; Smith J; Jones M; Reynolds C; Ozerovitch L; Chaudhry A; Wilson R; Rose M; et alAltmann DM. (Apr 2008). Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol. 152:95-101. DOI.
  • Altmann DM. (Jan 2008). Regulation, FoxP3, suppression and immunity. IMMUNOLOGY. 123:1-2. DOI.
  • Faulkner L; Altmann DM; Ellmerich S; Huhtaniemi I; Stamp G; Sriskandan S. (1 Sep 2007). Sexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha-induced hepatic apoptosis. AM J RESP CRIT CARE. 176:473-482. DOI.
  • Altmann DM. T-cell immunity and prion-protein 129 polymorphism in vCJD. Lancet Neurol. 7:554-555.
  • Boyton RJ; Altmann DM. (Jul 2007). Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 149:1-8. DOI.
  • von Delwig A; Altmann DM; Charlton FG; McKie N; Isaacs JD; Holmdahl R; Robinson JH. (May 2007). T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice. Ann Rheum Dis. 66:599-604. DOI.
  • Isaacs JD; Ingram RJ; Collinge J; Altmann DM; Jackson GS. (Nov 2006). The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J Neuropathol Exp Neurol. 65:1059-1068. DOI.
  • Boyton RJ; Reynolds C; Wahid FN; Jones MG; Ozerovitch L; Ahmad T; Chaudhry A; Jewell DP; et alKon OM; Smith J; Rose M; Newman-Taylor AJ; Cole P; Wilson R; Altmann DM. (Oct 2006). IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens. 68:325-330. DOI.
  • Isaacs JD; Jackson GS; Altmann DM. (Oct 2006). The role of the cellular prion protein in the immune system. Clin Exp Immunol. 146:1-8. DOI.
  • Llewelyn M; Sriskandan S; Terrazzini N; Cohen J; Altmann DM. (Oct 2006). The TCR Vbeta signature of bacterial superantigens spreads with stimulus strength. Int Immunol. 18:1433-1441. DOI.
  • von Delwig A; Hilkens CM; Altmann DM; Holmdahl R; Isaacs JD; Harding CV; Robertson H; McKie N; et alRobinson JH. (2006). Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice. Arthritis Res Ther. 8:R93. DOI.
  • Griesenbach U; Boyton RJ; Somerton L; Garcia SE; Ferrari S; Owaki T; Ya-Fen Z; Geddes DM; et alHasegawa M; Altmann DM; Alton EW. (Mar 2006). Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung. Gene Ther. 13:449-456. DOI.
  • Boyton RJ; Smith J; Ward R; Jones M; Ozerovitch L; Wilson R; Rose M; Trowsdale J; et alAltmann DM. (1 Feb 2006). HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med. 173:327-333. DOI.
  • von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH. (Feb 2006). The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. Arthritis Rheum. 54:482-491. DOI.
  • Faulkner L; Cooper A; Fantino C; Altmann DM; Sriskandan S. (15 Nov 2005). The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J Immunol. 175:6870-6877.
  • Boyton RJ; Davies S; Fantino C; Reynolds C; Portugal K; Dewchand H; Altmann DM. (Sep 2005). Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. INT IMMUNOL. 17:1157-1165. DOI.
  • Boyton RJ; Altmann DM; Wright A; Kon OM. (2007). Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis. Respiration. 74:462-466. DOI.
  • Altmann DM. (Jun 2005). Developing vaccines to counter bioterrorist threats. Expert Rev Vaccines. 4:275-279. DOI.
  • Davies S; Nicholson T; Laura M; Giovannoni G; Altmann DM. (May 2005). Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis. J Neuropathol Exp Neurol. 64:371-377.
  • Hall AM; Cairns LS; Altmann DM; Barker RN; Urbaniak SJ. (1 Mar 2005). Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood. 105:2175-2179. DOI.
  • Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; et alAmor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM. (15 Feb 2005). High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model. J Immunol. 174:1938-1946.
  • Illés Z; Stern JN; Reddy J; Waldner H; Mycko MP; Brosnan CF; Ellmerich S; Altmann DM; et alSantambrogio L; Strominger JL; Kuchroo VK. (10 Aug 2004). Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc Natl Acad Sci U S A. 101:11749-11754. DOI.
  • Ellmerich S; Takacs K; Mycko M; Waldner H; Wahid F; Boyton RJ; Smith PA; Amor S; et alBaker D; Hafler DA; Kuchroo VK; Altmann DM. (Jul 2004). Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis. Eur J Immunol. 34:1839-1848. DOI.
  • Boyton RJ; Altmann DM. (Apr 2004). Asthma: new developments in cytokine regulation. Clin Exp Immunol. 136:13-14. DOI.
  • Llewelyn M; Sriskandan S; Peakman M; Ambrozak DR; Douek DC; Kwok WW; Cohen J; Altmann DM. (1 Feb 2004). HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol. 172:1719-1726.
  • Altmann DM; Boyton RJ. (Aug 2003). Reciprocal conditioning: T cells as regulators of dendritic cell function. Immunology. 109:473-475.
  • Boyton RJ; Altmann DM. (Nov 2002). Is selection for TCR affinity a factor in cytokine polarization?. Trends Immunol. 23:526-529.
  • Unnikrishnan M; Altmann DM; Proft T; Wahid F; Cohen J; Fraser JD; Sriskandan S. (1 Sep 2002). The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol. 169:2561-2569.
  • Boyton RJ; Zaccai N; Jones EY; Altmann DM. (1 Feb 2002). CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3. J Immunol. 168:1018-1027.
  • Boyton RJ; Altmann DM. (Jan 2002). Transgenic models of autoimmune disease. Clin Exp Immunol. 127:4-11.
  • Sriskandan S; Unnikrishnan M; Krausz T; Dewchand H; Van Noorden S; Cohen J; Altmann DM. (15 Jul 2001). Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J Infect Dis. 184:166-173. DOI.
  • Perraudeau M; Taylor PR; Stauss HJ; Lindstedt R; Bygrave AE; Pappin DJ; Ellmerich S; Whitten A; et alRahman D; Canas B; Walport MJ; Botto M; Altmann DM. (Oct 2000). Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice. Eur J Immunol. 30:2871-2880. DOI.
  • Douek DC; Altmann DM. (Feb 2000). T-cell apoptosis and differential human leucocyte antigen class II expression in human thymus. Immunology. 99:249-256.
  • Birk OS; Gur SL; Elias D; Margalit R; Mor F; Carmi P; Bockova J; Altmann DM; et alCohen IR. (27 Apr 1999). The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci U S A. 96:5159-5163.
  • Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; et alFlavell RA; Altmann DM. (Dec 1998). Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. Int Immunol. 10:1765-1776.
  • Takács K; Altmann DM. (Aug 1998). The case against epitope spread in experimental allergic encephalomyelitis. Immunol Rev. 164:101-110.
  • Takács K; Chandler P; Altmann DM. (Nov 1997). Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread. Eur J Immunol. 27:2927-2934. DOI.
  • Reizis B; Altmann DM; Cohen IR. (Oct 1997). Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice. Eur J Immunol. 27:2478-2483. DOI.
  • Elliott JI; Dewchand H; Altmann DM. (Jul 1997). Streptozotocin-induced diabetes in mice lacking alphabeta T cells. Clin Exp Immunol. 109:116-120.
  • Newton SG; Altmann DM. (May 1997). Analysis of heat shock protein 60 epitopes in transgenic mice. Biochem Soc Trans. 25:308S.
  • Rosloniec EF; Brand DD; Myers LK; Whittington KB; Gumanovskaya M; Zaller DM; Woods A; Altmann DM; et alStuart JM; Kang AH. (17 Mar 1997). An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 185:1113-1122.
  • Douek DC; Altmann DM. (Mar 1997). HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol. 9:355-364.
  • Elliott JI; Douek DC; Altmann DM. (Nov 1996). Mice lacking alpha beta + T cells are resistant to the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol. 70:139-144.
  • Douek DC; Corley KT; Zal T; Mellor A; Dyson PJ; Altmann DM. (Sep 1996). Negative selection by endogenous antigen and superantigen occurs at multiple thymic sites. Int Immunol. 8:1413-1420.
  • Elliott JI; Altmann DM. (Apr 1996). Non-obese diabetic mice hemizygous at the T cell receptor alpha locus are susceptible to diabetes and sialitis. Eur J Immunol. 26:953-956. DOI.
  • Birk OS; Douek DC; Elias D; Takacs K; Dewchand H; Gur SL; Walker MD; van der Zee R; et alCohen IR; Altmann DM. (6 Feb 1996). A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A. 93:1032-1037.
  • Takács K; Douek DC; Altmann DM. (Nov 1995). Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice. Eur J Immunol. 25:3134-3141. DOI.
  • Elliott JI; Altmann DM. (1 Oct 1995). Dual T cell receptor alpha chain T cells in autoimmunity. J Exp Med. 182:953-959.
  • Chandler P; Frater AJ; Douek DC; Viney JL; Kay G; Owen MJ; Hayday AC; Simpson E; et alAltmann DM. (Aug 1995). Immune responsiveness in mutant mice lacking T-cell receptor alpha beta+ cells. Immunology. 85:531-537.
  • Altmann DM; Douek DC; Frater AJ; Hetherington CM; Inoko H; Elliott JI. (1 Mar 1995). The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med. 181:867-875.
  • ALTMANN DM; TAKACS K; ELLIOTT JI. (1994). HLA-DR AND H-2E TRANSGENES DIFFERENTIALLY MEDIATE T-CELL RECEPTOR-SPECIFIC POSITIVE SELECTION. J CELL BIOCHEM. 450-450.
  • Simpson E; Takacs K; Altmann DM. (1994). Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules. Thymus. 23:1-13.
  • Elliott JI; Takács K; Altmann DM. (Oct 1993). HLA-DR and H-2E transgenes differentially mediate TCR-specific positive selection. Int Immunol. 5:1279-1284.
  • Altmann DM; Takács K; Trowsdale J; Elliott JI. (Jul 1993). Mouse mammary tumor virus-mediated T-cell receptor negative selection in HLA-DRA transgenic mice. Hum Immunol. 37:149-156.
  • Simpson E; Dyson PJ; Knight AM; Robinson PJ; Elliott JI; Altmann DM. (Feb 1993). T-cell receptor repertoire selection by mouse mammary tumor viruses and MHC molecules. Immunol Rev. 131:93-115.
  • Chan KH; Yip TC; Altmann DM; Ng MH. (15 Apr 1992). Involvement of major histocompatibility complex class II antigen in Epstein-Barr virus-mediated B cell proliferation. Cell Immunol. 141:169-181.
  • Altmann DM. (1992). HLA-DQ associations with autoimmune disease. Autoimmunity. 14:79-83.
  • Altmann DM; Sansom D; Marsh SG. (Aug 1991). What is the basis for HLA-DQ associations with autoimmune disease?. Immunol Today. 12:267-270.
  • Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM. (Jan 1991). Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements. Eur J Immunol. 21:79-88. DOI.
  • Merkenschlager M; Altmann DM; Ikeda H. (15 Nov 1990). T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4. J Immunol. 145:3181-3187.
  • ALTMANN DM. (Nov 1990). CORRECTION. IMMUNOGENETICS. 32:370-370.
  • Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; et alKappos L; Wekerle H. (Oct 1990). Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A. 87:7968-7972.
  • Altmann DM; Wilkinson D; Ikeda H; Trowsdale J. (1990). Analysis of antigen presentation using HLA transfectants. Immunol Res. 9:57-68.
  • Altmann DM; Heyes JM; Ikeda H; Sadler AM; Wilkinson D; Madrigal JA; Bodmer JG; Trowsdale J. (1990). Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells. Immunogenetics. 32:51-55.
  • Altmann DM; Wilkinson D; Trowsdale J. (1990). Transfection of genes for cell surface products involved in antigen presentation--applications to the understanding of autoimmunity. Autoimmunity. 7:213-220.
  • Altmann DM; Trowsdale J. (Oct 1989). Major histocompatibility complex structure and function. Curr Opin Immunol. 2:93-98.
  • Altmann DM; Hogg N; Trowsdale J; Wilkinson D. (6 Apr 1989). Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature. 338:512-514. DOI.
  • Wilkinson D; de Vries RR; Madrigal JA; Lock CB; Morgenstern JP; Trowsdale J; Altmann DM. (1 Apr 1988). Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med. 167:1442-1458.
  • Altmann DM; Lider O; Douek DC; Cohen IR. (Nov 1987). Activation of specific T cell lines by the antigens avidin and myelin basic protein in the absence of antigen-presenting cells. Eur J Immunol. 17:1635-1640. DOI.
  • Altmann DM; Blyth WA. (Jun 1985). Protection from herpes simplex virus-induced neuropathology in mice showing delayed hypersensitivity tolerance. J Gen Virol. 66 ( Pt 6):1297-1303.
  • COHEN IR; ALTMANN DM; FRIEDMAN A. (1985). THE ADVANTAGE OF BEING A LOW RESPONDER. IMMUNOL TODAY. 6:147-148.
  • Altmann DM; Blyth WA. (Jan 1985). The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus. Clin Exp Immunol. 59:17-22.
  • Altmann DM; Blyth WA. (Nov 1984). Lipopolysaccharide-induced suppressor cells for delayed-type hypersensitivity to herpes simplex virus: nature of suppressor cell and effect on pathogenesis of herpes simplex. Immunology. 53:473-480.
  • Hill TJ; Altmann DM; Blyth WA; Harbour DA; Whitby A. (Apr 1984). Herpes simplex virus latency. Clin Dermatol. 2:46-55.

Conferences

  • Harris AJ; Durrenberger P; Kamel F; Ettorre A; Nicholas R; Malik O; Altmann DM. Investigating the role of natural killer cell subsets in multiple sclerosis. 131:125-125. (Dec 2010).
  • Lowther DE; Ascough S; Ettorre A; Altmann DM. Mechanism of disease in a spontaneous, humanised multiple sclerosis model - the relative role of Th1, Th17 and Treg cells. 131:39-40. (Dec 2010).
  • Ingram RJ; Chu K; Metan G; Ascough S; Doganay M; Sriskandan S; Altmann DM. T cell epitope mapping anthrax: the detection of CD4 epitopes in lethal factor. 125:144-144. (Dec 2008).
  • Chong DLW; Ingram RJ; Altmann DM; Skriskandan S. The involvement of TLR2 in activation of Tregs during Streptococcus pyogenes acute infection. 125:116-116. (Dec 2008).
  • Ingram RJ; Chong DLW; Turner CE; Sriskandan S; Altmann DM. The role of T cells in acute Streptococcus pyogenes infection. 125:62-62. (Dec 2008).
  • ALTMANN DM; WILKINSON D; IKEDA H; TROWSDALE J. DISSECTION OF THE ROLES OF SPECIFIC CLASS-II ANTIGENS AND ACCESSORY MOLECULES IN ANTIGEN PRESENTATION. 38:71-83. (1990).
  • Illes Z; Stern JNH; Reddy J; Waldner H; Mycko MP; Brosnan CF; Ellmerich S; Altmann DM; et alSantambrogio L; Strominger JL; Kuchroo VK. Novel synthetic amino acid copolymers suppress MBP 85-99-induced EAE in humanised double-transgenic mice through different effects on T cell responses. 20th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple- Sclerosis/9th Annual Meeting of Rehabilitation in MS. 10:S200-S200. (Sep 2004).
  • Lowes K; von Delwig AA; McKie N; Altmann DM; Goodacre JA; Rowan AD; Robinson JH. Specificity of CD4 T-cell responses to aggrecan in BALB/c and DR1 transgenic mice. 25th European Workshop for Rheumatology Research. 7:S7-S7. (Feb 2005).
  • Llewelyn M; Sriskandan S; Terrazzini N; Cohen J; Altmann DM. The V beta specific response to bacterial superantigens is determined by concentration and HLA class II. 120:77-77. (Mar 2007).
  • von Delwig A; Wilson AJ; Altmann DM; Holmdahl R; Harding CV; Mckie N; Isaacs JD; Lakey JH; et alRobinson JH. Febrile temperatures enhance antigen processing of type II collagen for presentation to CD4 T cells. 54:S639-S639. (Sep 2006).
  • von Delwig A; Wilson A; Altmann DM; Holmdahl R; Harding CV; McKie N; Isaacs JD; Lakey JH; et alRobinson JH. Febrile temperatures enhance antigen processing of type II collagen for presentation to CD4 T cells. 54:S37-S37. (Sep 2006).
  • von Delwig A; Altmann DM; Isaacs JD; Holmdahl R; McKie N; Robinson JH. Human type II collagen is processed in lysosomal compartments of macrophages for presentation of the glycosylated arthritogenic epitope hCII(259-273) to CD4 T cells in HLA-DR1 transgenic mice. 7:S9-S9. (Feb 2005). DOI.
  • Campbell D; Gronlund H; van Hage-Hamsten M; Altmann DM; Lloyd CM; Larche M. Peptide immunotherapy in Fel d 1-sensitized HLA-DR1 transgenic mice is associated with increased IL-10 but independent of TGFbeta and Foxp3 expression. 117:S327-S327. (Feb 2006).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook
 
Recent Alumni